The overall goal of Dr. Hwang´s research is to elucidate molecular mechanisms by which different types of dietary fatty acids modify risks of chronic diseases. Dr. Hwang has been investigating how different dietary fatty acids modulate receptor-mediated signaling pathways, target gene expression, and subsequent cellular responses. Further aim is to determine how this modulation is related to risks of developing chronic diseases.
Growing evidence now suggests that fatty acids, in addition to their roles as structural components of membrane lipids and as precursors of eicosanoids, can act as second messengers or regulators of signal transducing molecules. The modulatory roles of dietary fatty acids on immune responses are understood largely based on experimental observations demonstrating the cause and effect relationship. However, molecular mechanisms by which fatty acids regulate immune and inflammatory responses are not well understood.
Results from Dr. Hwang's recent studies demonstrated that saturated fatty acids activate NFkB and the expression of mitogen inducible cyclooxygenase (COX-2) in macrophages. However, all unsaturated fatty acids tested inhibit NFkB activation and COX-2 expression induced by saturated fatty acids or bacterial lipopolysaccharide (LPS). Furthermore, this modulation by fatty acids is mediated through toll-like receptors (TLR)-derived signaling pathways. Toll-like receptors play a critical role in the induction of inflammatory and immune responses against pathogen associated molecular patterns.
These results document a novel mechanism by which fatty acids modulate the expression of COX-2 and further suggest that TLR-mediated signaling pathways, target gene expressions, and subsequent inflammatory and immune responses can be differentially modulated by the types of dietary fatty acids consumed. Since inflammation is considered as an important risk for many chronic diseases, these results suggest the possibility that beneficial or detrimental effects of different types of dietary fatty acids on the risk of the development of many chronic inflammatory diseases are in part mediated through the modulation of TLRs.